Showing results 4 to 10 of 10
< previous
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Pharmacological inhibition of PHGDH enhances temozolomide efficacy via decreasing MGMT expression and ROS-induced DNA damage in glioblastoma Proceeding/Conference:27th Annual Scientific Meeting (Virtual Conference) of The Hong Kong Neurosurgical Society, 2020 | 2020 | ||
| 2018 | |||
Targeting stress response in chemo-resistant glioblastoma using albumin-encapsulated nanoparticles Proceeding/Conference:2nd International Congress of Asian Oncology Society in Conjunction with the 48th Annual Meeting of Korean Cancer Association (Virtual), Korea, 16-18 June 2022 | 2022 | ||
Targeting unfolded protein response using albumin-encapsulated nanoparticle attenuates temozolomide resistance in glioblastoma (Poster Presentation) Proceeding/Conference:Brain tumour conference, London, United Kingdom, 5-7 September 2022 | 2022 | ||
The clinical significance of ADD3 in glioblastoma Proceeding/Conference:27th Annual Scientific Meeting (Virtual Conference) of The Hong Kong Neurosurgical Society, 2020 | 2020 | ||
The role of cytoskeleton protein adducing 3 in modulating epithelial-mesenchymal transition in glioblastoma Proceeding/Conference:47th Annual Meeting of Korean Cancer Association and 7th International Cancer Conference (Virtual), Korea, 17-18 June 2021 | 2021 | ||
Vitamin D enhances temozolomide anti-tumour efficacy in human glioblastoma multiforme: in vitro and in vivo studies (Poster presentation) Proceeding/Conference:27th Annual Scientific Meeting (Virtual Conference), The Hong Kong Neurosurgical Society, Hong Kong, 18-19 December 2020 | 2020 |